They guided not to expect (based on previous, large long-term cardiovascular outcomes trial, which were done by different type of drug) but did not rule out the possibility (based on JELIS trial, that was "similar").
When any sponsor of double-blinded study said / guaranteed an early stop with 100% certainty before interim analysis?